Roswell Park in the News

A Roswell Park Cancer Institute researcher will use a $100,000 award to develop a blood-based test for diagnosing lung cancer.

A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer....

Jenny Miller of Athens, Penn., had surgery last year for malignant fibrous histiosarcoma at a local hospital. Although she wondered if she was wasting her time, she went for a second opinion at Roswell Park Cancer Institute in Buffalo, N.Y.